Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr:202:107111.
doi: 10.1016/j.phrs.2024.107111. Epub 2024 Feb 19.

In vitro models for neuropathic pain phenotypic screening in brain therapeutics

Affiliations
Free article
Review

In vitro models for neuropathic pain phenotypic screening in brain therapeutics

A L Martínez et al. Pharmacol Res. 2024 Apr.
Free article

Abstract

The discovery of brain therapeutics faces a significant challenge due to the low translatability of preclinical results into clinical success. To address this gap, several efforts have been made to obtain more translatable neuronal models for phenotypic screening. These models allow the selection of active compounds without predetermined knowledge of drug targets. In this review, we present an overview of various existing models within the field, examining their strengths and limitations, particularly in the context of neuropathic pain research. We illustrate the usefulness of these models through a comparative review in three crucial areas: i) the development of novel phenotypic screening strategies specifically for neuropathic pain, ii) the validation of the models for both primary and secondary screening assays, and iii) the use of the models in target deconvolution processes.

Keywords: Early drug discovery; Felodipine (PubChem CID: 3333); Immortalized cell lines; In vitro models; In vitro pharmacology; Melatonin (PubChem CID: 896); Neuropathic pain; Nicardipine (PubChem CID: 4474); Nimodipine (PubChem CID: 4497); Nitrendipine (PubChem CID: 4507); Phenotypic screening; Pregabalin (PubChem CID: 5486971); Protriptyline (PubChem CID: 4976); Rilpivirine (PubChem CID: 6451164); Vincristine (PubChem CID: 5978); Zalcitabine (PubChem CID: 24066); α-lipoic acid (PubChem CID: 53259805).

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

LinkOut - more resources